The alternative splicing factor Nova2 regulates vascular development and lumen formation

• Published in: Nature communications Vol. 6; no. 1; p. 8479
• Main Authors: Giampietro, Costanza, Deflorian, Gianluca, Gallo, Stefania, Di Matteo, Anna, Pradella, Davide, Bonomi, Serena, Belloni, Elisa, Nyqvist, Daniel, Quaranta, Valeria, Confalonieri, Stefano, Bertalot, Giovanni, Orsenigo, Fabrizio, Pisati, Federica, Ferrero, Elisabetta, Biamonti, Giuseppe, Fredrickx, Evelien, Taveggia, Carla, Wyatt, Chris D R, Irimia, Manuel, Di Fiore, Pier Paolo, Blencowe, Benjamin J, Dejana, Elisabetta, Ghigna, Claudia
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 08.10.2015; Nature Pub. Group
• Subjects: Alternative Splicing - physiology; Angiogenesis; Angiogènesi; Animals; Antigens, Neoplasm - genetics; Antigens, Neoplasm - metabolism; Blood vessels; Cells, Cultured; Endothelial Cells - metabolism; Endothelium, Vascular - physiology; Fisiologia; Medicin och hälsovetenskap; Mice; Neovascularization, Physiologic - physiology; Neuro-Oncological Ventral Antigen; Neurones; Oncology; RNA-Binding Proteins - genetics; RNA-Binding Proteins - metabolism; Italy; Sweden; Spain
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/ncomms9479

Vascular lumen formation is a fundamental step during angiogenesis; yet, the molecular mechanisms underlying this process are poorly understood. Recent studies have shown that neural and vascular systems share common anatomical, functional and molecular similarities. Here we show that the organization of endothelial lumen is controlled at the post-transcriptional level by the alternative splicing (AS) regulator Nova2, which was previously considered to be neural cell-specific. Nova2 is expressed during angiogenesis and its depletion disrupts vascular lumen formation in vivo. Similarly, Nova2 depletion in cultured endothelial cells (ECs) impairs the apical distribution and the downstream signalling of the Par polarity complex, resulting in altered EC polarity, a process required for vascular lumen formation. These defects are linked to AS changes of Nova2 target exons affecting the Par complex and its regulators. Collectively, our results reveal that Nova2 functions as an AS regulator in angiogenesis and is a novel member of the 'angioneurins' family.